Efficacy of Risankizumab Dose Escalation Among Patients With Inflammatory Bowel Disease. Schreiber-Stainthorp W, Faye AS, Axelrad JE. Inflamm Bowel Dis 2025 Jun 24:izaf130. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Schreiber-Stainthorp W, Faye AS, Axelrad JE. Efficacy of Risankizumab Dose Escalation Among Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2025 Jun 24:izaf130. doi: 10.1093.
PMID: 40554625